PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
IXJ vs. GERM
Performance
Return for Risk
Drawdowns
Volatility
Dividends

IXJ vs. GERM

Last updated Jun 24, 2026

IXJ (iShares Global Healthcare ETF) and GERM (Amplify Treatments, Testing and Advancements ETF) are both Health & Biotech Equities funds - IXJ tracks the S&P Global 1200 Health Care (Sector) Capped Index while GERM tracks the Prime Treatments, Testing and Advancements Index. Both are passively managed. Over the past year, IXJ returned 13.71% vs 0.00% for GERM. IXJ charges 0.40%/yr vs 0.68%/yr for GERM.

Performance

IXJ vs. GERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Global Healthcare ETF (IXJ) and Amplify Treatments, Testing and Advancements ETF (GERM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

IXJ

1D
1.45%
1M
0.89%
YTD
-1.76%
6M
-1.97%
1Y
13.71%
3Y*
5.44%
5Y*
4.16%
10Y*
8.54%

GERM

1D
0.00%
1M
0.00%
YTD
0.00%
6M
0.00%
1Y
0.00%
3Y*
—
5Y*
—
10Y*
—
*Multi-year figures are annualized to reflect compound growth (CAGR)

IXJ vs. GERM - Yearly Performance Comparison

2026 (YTD)20252024
IXJ
iShares Global Healthcare ETF		-1.76%14.99%-12.51%
GERM
Amplify Treatments, Testing and Advancements ETF		0.00%0.00%0.00%

IXJ vs. GERM - Sectors Allocation Comparison

Sectors
IXJ
GERM

Healthcare

98.5%
99.3%

Consumer Defensive

0.5%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Energy

-

-

Financial Services

-

0.4%

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

IXJ
98.5%
GERM
99.3%

Consumer Defensive

IXJ
0.5%
GERM

-

Basic Materials

IXJ

-

GERM

-

Communication Services

IXJ

-

GERM

-

Consumer Cyclical

IXJ

-

GERM

-

Energy

IXJ

-

GERM

-

Financial Services

IXJ

-

GERM
0.4%

Industrials

IXJ

-

GERM

-

Real Estate

IXJ

-

GERM

-

Technology

IXJ

-

GERM

-

Utilities

IXJ

-

GERM

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

iShares Global Healthcare ETF

Amplify Treatments, Testing and Advancements ETF

Often compared with IXJ:
IXJ vs. XLVIXJ vs. VHTIXJ vs. IHIIXJ vs. XDWH.LIXJ vs. FHLCIXJ vs. IVVIXJ vs. HLTH.L
Often compared with GERM:
GERM vs. SBIOGERM vs. EQRRGERM vs. XBIGERM vs. GDOCGERM vs. ARKGGERM vs. XLVGERM vs. IHE

Return for Risk

IXJ vs. GERM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
IXJ
IXJ Risk / Return Rank: 2626
Overall Rank
IXJ Sharpe Ratio Rank: 2727
Sharpe Ratio Rank
IXJ Sortino Ratio Rank: 2828
Sortino Ratio Rank
IXJ Omega Ratio Rank: 2525
Omega Ratio Rank
IXJ Calmar Ratio Rank: 2727
Calmar Ratio Rank
IXJ Martin Ratio Rank: 2424
Martin Ratio Rank
GERM

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IXJ vs. GERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Global Healthcare ETF (IXJ) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

IXJGERMDifference
Sharpe ratioReturn per unit of total volatility
0.93

—

—

Sortino ratioReturn per unit of downside risk
1.49

—

—

Omega ratioGain probability vs. loss probability

1.17

—

—

Calmar ratioReturn relative to maximum drawdown

1.28

—

—

Martin ratioReturn relative to average drawdown

3.02

—

—

IXJ vs. GERM - Sharpe Ratio Comparison

Loading charts...

Drawdowns

IXJ vs. GERM - Drawdown Comparison

The maximum IXJ drawdown since its inception was -40.60%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for IXJ and GERM.

Loading charts...

Drawdown Indicators

IXJGERMDifference

Max Drawdown

Largest peak-to-trough decline

-40.60%

0.00%

-40.60%

Max Drawdown (1Y)

Largest decline over 1 year

-10.78%

0.00%

-10.78%

Max Drawdown (3Y)

Largest decline over 3 years

-18.14%

—

—

Max Drawdown (5Y)

Largest decline over 5 years

-18.14%

—

—

Max Drawdown (10Y)

Largest decline over 10 years

-27.35%

—

—

Current Drawdown

Current decline from peak

-5.93%

0.00%

-5.93%

Average Drawdown

Average peak-to-trough decline

-6.92%

0.00%

-6.92%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.56%

0.00%

+4.56%

Volatility

IXJ vs. GERM - Volatility Comparison

iShares Global Healthcare ETF (IXJ) has a higher volatility of 5.06% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that IXJ's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

IXJGERMDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.06%

0.00%

+5.06%

Volatility (6M)

Calculated over the trailing 6-month period

10.49%

0.00%

+10.49%

Volatility (1Y)

Calculated over the trailing 1-year period

14.87%

0.00%

+14.87%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

14.28%

0.00%

+14.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

15.67%

0.00%

+15.67%

IXJ vs. GERM - Expense Ratio Comparison

IXJ has a 0.40% expense ratio, which is lower than GERM's 0.68% expense ratio.

Dividends

IXJ vs. GERM - Dividend Comparison

IXJ's dividend yield for the trailing twelve months is around 1.52%, while GERM has not paid dividends to shareholders.

PositionTTM20252024202320222021202020192018201720162015
GERM
Amplify Treatments, Testing and Advancements ETF		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
IXJ
iShares Global Healthcare ETF		1.52%1.40%1.50%1.38%1.17%1.12%1.27%1.42%2.11%1.46%1.73%2.85%

Frequently Asked Questions

IXJ has higher volatility (5.06%) compared to GERM (0.00%). In terms of maximum drawdown, IXJ dropped -40.60% vs GERM's 0.00%.

On 1-year performance, IXJ leads with 13.71% vs 0.00% for GERM. On fees, IXJ is cheaper at 0.40% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, IXJ has performed better with a 13.71% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IXJ is cheaper with a 0.40% expense ratio, compared with 0.68% for GERM.

IXJ has the higher dividend yield at 1.52%, compared with 0.00% for GERM.

IXJ tracks S&P Global 1200 Health Care (Sector) Capped Index, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: iShares and Amplify. Their fees differ too: 0.40% for IXJ and 0.68% for GERM.

Portfolio Optimizer

Find the right allocation for IXJ and GERM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer